Guggenheim Capital’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-374,871
Closed -$2.32M 2283
2018
Q3
$2.32M Sell
374,871
-46,177
-11% -$209K 0.02% 1154
2018
Q2
$2.69M Sell
421,048
-6,787
-2% -$48.3K 0.02% 1070
2018
Q1
$2.98M Sell
427,835
-143,667
-25% -$1.67M 0.01% 1357
2017
Q4
$7.21M Sell
571,502
-34,806
-6% -$424K 0.02% 832
2017
Q3
$7.2M Buy
606,308
+155,899
+35% +$2.31M 0.02% 850
2017
Q2
$6.74M Buy
450,409
+66,213
+17% +$883K 0.02% 853
2017
Q1
$3.66M Buy
384,196
+352
+0.1% +$2.97K 0.01% 1207
2016
Q4
$3.4M Buy
383,844
+100,497
+35% +$903K 0.01% 1265
2016
Q3
$2.43M Sell
283,347
-576
-0.2% -$4.56K 0.01% 1493
2016
Q2
$2.27M Sell
283,923
-13,771
-5% -$107K 0.01% 1486
2016
Q1
$2.6M Sell
297,694
-69,969
-19% -$581K 0.01% 1394
2015
Q4
$3.44M Sell
367,663
-23,888
-6% -$207K 0.01% 1234
2015
Q3
$3.78M Buy
391,551
+220,750
+129% +$2.33M 0.01% 1183
2015
Q2
$1.98M Buy
+170,801
New +$1.76M ﹤0.01% 1779

Other funds holding MDXG

Guggenheim Capital's MDXG Position: Q4 2018 in Review

Guggenheim Capital sold out of MiMedx Group (MDXG) in Q4 2018, closing a stake of 374,871 shares — an estimated $2.32M sold.

Guggenheim Capital first reported a position in MDXG in Q2 2015 and held it in 14 quarters. The position peaked at $7.21M in Q4 2017. 38 funds tracked by Wall St. Rank hold MDXG as of Q4 2018.

  • Guggenheim Capital reported no remaining MiMedx Group position as of Q4 2018 after selling out during the quarter.
  • Guggenheim Capital sold 374,871 MiMedx Group shares in Q4 2018, an estimated $2.32M.
  • Guggenheim Capital first reported a position in MiMedx Group in Q2 2015 and held it in 14 quarters.
  • Guggenheim Capital's MiMedx Group position peaked at $7.21M in Q4 2017.
  • 38 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2018.

Based on Guggenheim Capital's 13F filing for Q4 2018, filed 14 Feb 2019.